<SEC-DOCUMENT>0001601830-23-000021.txt : 20230508
<SEC-HEADER>0001601830-23-000021.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508080031
ACCESSION NUMBER:		0001601830-23-000021
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230508
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RECURSION PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001601830
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				464099738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40323
		FILM NUMBER:		23895904

	BUSINESS ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101
		BUSINESS PHONE:		(385) 269-0203

	MAIL ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Recursion Pharmaceuticals, LLC
		DATE OF NAME CHANGE:	20140305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rxrx-20230508.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d44ab27f-8d2b-476f-a18d-ac4021c2411b,g:867c0a93-9133-4bf0-a465-6221de68719c,d:3515f90243794557b6b778e9763d5abc--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rxrx-20230508</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY180L2ZyYWc6ZmIwMzQzODU1YzA4NDg2M2JhZjkyYjI2N2ExZGQ2YWYvdGFibGU6YTk1YjRjYjdlNWI1NDM5OGE5OWRkMzZmMmQ1NGE4ZWYvdGFibGVyYW5nZTphOTViNGNiN2U1YjU0Mzk4YTk5ZGQzNmYyZDU0YThlZl8xLTEtMS0xLTEwMTQ0Mw_33c76cd7-af83-4710-8881-51c1ebf5ff7c">0001601830</ix:nonNumeric><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY180L2ZyYWc6ZmIwMzQzODU1YzA4NDg2M2JhZjkyYjI2N2ExZGQ2YWYvdGFibGU6YTk1YjRjYjdlNWI1NDM5OGE5OWRkMzZmMmQ1NGE4ZWYvdGFibGVyYW5nZTphOTViNGNiN2U1YjU0Mzk4YTk5ZGQzNmYyZDU0YThlZl8yLTEtMS0xLTEwMTQ0Mw_7536b49c-a71a-4139-9076-aade82727435">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rxrx-20230508.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-13</xbrli:startDate><xbrli:endDate>2023-01-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3515f90243794557b6b778e9763d5abc_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjUz_86f660b8-5266-4b8e-b9f1-052c4ba89471">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of The Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yMjc_5705ffd0-c431-45e2-a788-110f7e72d926">May&#160;8, 2023</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yMzE_2747b360-915f-47da-b962-662a70ba83e4">RECURSION PHARMACEUTICALS, INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6YzQ2MDlkMjU4MDU0NDcyNWEwYjlmOGM5Mjg3YzllMmYvdGFibGVyYW5nZTpjNDYwOWQyNTgwNTQ0NzI1YTBiOWY4YzkyODdjOWUyZl8wLTAtMS0xLTEwMTQ0Mw_504502c4-7525-46ef-9440-742a556c2272">Delaware</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6YzQ2MDlkMjU4MDU0NDcyNWEwYjlmOGM5Mjg3YzllMmYvdGFibGVyYW5nZTpjNDYwOWQyNTgwNTQ0NzI1YTBiOWY4YzkyODdjOWUyZl8wLTItMS0xLTEwMTQ0Mw_9a5d9f57-f228-4263-af50-686d148ba309">001-40323</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#160;<ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6YzQ2MDlkMjU4MDU0NDcyNWEwYjlmOGM5Mjg3YzllMmYvdGFibGVyYW5nZTpjNDYwOWQyNTgwNTQ0NzI1YTBiOWY4YzkyODdjOWUyZl8wLTQtMS0xLTEwMTQ0Mw_9d5165b2-eabf-4a29-82ee-6d89a4a4055a">46-4099738</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yOTQ_db5b0049-ed1a-4505-a86a-f4ab0033c97e">41 S Rio Grande Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yOTc_876f19de-c11d-4eb4-97a8-dbf0fb500381">Salt Lake City,</ix:nonNumeric> <ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zMDA_8f0710fd-8073-4447-a27d-145a6a783501">UT</ix:nonNumeric> <ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zMDM_2dad24d7-3771-49e2-8203-1694c0a2f7c1">84101</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zNjA_f964c9e9-c38f-4238-b074-aee900320fad">385</ix:nonNumeric>) <ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zNjQ_a8c469ac-975c-4a14-90ba-851556fe9457">269 - 0203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjU1_64938900-b014-46e6-8a5b-14263586c2a9">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjU5_fd67078f-8e0d-4393-86b2-625039ae3fa8">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjU2_c34dd2da-3b14-4aa3-8c29-097de0551d22">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjUy_e66e4e68-cbb9-43e8-bce8-da34bde790ec">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6ZGJhMWZjZGNlOTVhNDQzN2FmNzBkNTg0NmI0MjY0Y2MvdGFibGVyYW5nZTpkYmExZmNkY2U5NWE0NDM3YWY3MGQ1ODQ2YjQyNjRjY18xLTAtMS0xLTEwMTQ0Mw_4733f9b4-c80e-45d6-b8f9-e0dd9fae57b4">Class A Common Stock, par value $0.00001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6ZGJhMWZjZGNlOTVhNDQzN2FmNzBkNTg0NmI0MjY0Y2MvdGFibGVyYW5nZTpkYmExZmNkY2U5NWE0NDM3YWY3MGQ1ODQ2YjQyNjRjY18xLTEtMS0xLTEwMTQ0Mw_528df04f-ed27-463f-96c2-b56a25eb2db7">RXRX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6ZGJhMWZjZGNlOTVhNDQzN2FmNzBkNTg0NmI0MjY0Y2MvdGFibGVyYW5nZTpkYmExZmNkY2U5NWE0NDM3YWY3MGQ1ODQ2YjQyNjRjY18xLTItMS0xLTEwMTQ0Mw_2d250473-8ed4-4727-9bb0-a7cce243036b">Nasdaq Global Select Market</ix:nonNumeric> </span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjYx_49212511-ba5f-48f5-9693-d52d91294d17">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></div><div><span><br/></span></div><div id="i3515f90243794557b6b778e9763d5abc_7"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.02.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cyclica, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 8, 2023, Recursion Pharmaceuticals, Inc. (&#8220;Recursion&#8221; or the &#8220;Company&#8221;) and a direct, wholly owned subsidiary of Recursion (the &#8220;Cyclica Purchaser&#8221;) entered into a Share Purchase Agreement (the &#8220;Cyclica Purchase Agreement&#8221;) pursuant to which, subject to applicable closing conditions, the Cyclica Purchaser will, among other things, acquire (the &#8220;Cyclica Acquisition&#8221;) 100% of the outstanding equity securities of Cyclica Inc. (&#8220;Cyclica&#8221;) for a purchase price of $40 million, subject to customary closing and post-closing purchase price adjustments, to be paid in the form of shares of Recursion Class A common stock (the &#8220;Class A Shares&#8221;), cash paid in lieu of shares to unaccredited investors as described below, and the assumption by Recursion of outstanding options to purchase shares of Cyclica. Assuming a purchase price of $40 million, following the completion of the Cyclica Acquisition, Recursion would issue up to approximately 6.9 million Class A Shares in the Cyclica Acquisition (including Class A Shares issuable upon the exercise of options to purchase shares of Cyclica assumed by Recursion in the Cyclica Acquisition, but excluding from the calculation any increase or decrease in the number of shares to be issued as a result of customary closing and post-closing purchase price adjustments and any cash paid in lieu of shares to unaccredited investors) based on a reference price of Class A Shares of $5.7837 (the &#8220;Reference Price&#8221;), which is the volume weighted average price of Class A Shares over the 30 days ended May 5, 2023. In addition, under the terms of the Cyclica Purchase Agreement, in certain circumstances Recursion may pay cash consideration to Cyclica shareholders in lieu of Class A Shares at a value based on the Reference Price, which may result in the issuance of fewer Class A Shares.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based in part upon the representations of the sellers in the Cyclica Purchase Agreement, the offering and sale of the Cyclica Consideration Shares was made in reliance on the exemption afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and the rules promulgated thereunder. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Valence Discovery Inc. Acquisition </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Also on May 8, 2023, Recursion </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and an indirect wholly owned subsidiary of Recursion </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Valence Purchaser&#8221;) entered into a Share Purchase Agreement (the &#8220;Valence Purchase Agreement&#8221;) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">pursuant to which, subject to applicable closing conditions, the Valence Purchaser will, among other things, acquire</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (the &#8220;Valence Acquisition&#8221;) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">100% of the outstanding equity securities of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Valence Discovery Inc. (&#8220;Valence&#8221;) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for a purchase price of $47.5 million, subject to customary closing and post-closing purchase price adjustments, to be paid in the form of (i) Class A Shares and shares of the Valence Purchaser (the &#8220;Exchangeable Shares&#8221;), cash paid in lieu of shares to unaccredited investors as described below, and the assumption by Recursion of outstanding options to purchase shares of Valence. Each Exchangeable Share will be exchangeable into one Class A Share at the option of the holder, subject to certain adjustments. Assuming a purchase price of $47.5 million, following the completion of the Valence Acquisition, Recursion will issue up to approximately 8.2 million Class A Shares in the Valence Acquisition (including Class A Shares issuable upon the exchange of Exchangeable Shares and upon the exercise of options to purchase shares of Valence assumed by Recursion in the Valence Acquisition, but excluding from the calculation any increase or decrease in the number of shares to be issued as a result of customary closing and post-closing purchase price adjustments and any cash paid in lieu of shares to unaccredited investors) based on the Reference Price. In addition, under the terms of the Valence Purchase Agreement, in certain circumstances Recursion may pay cash consideration to Valence shareholders in lieu of Exchangeable Shares or Class A Shares at a value based on the Reference Price, which may result in the issuance of fewer Class A Shares (including Class A Shares issuable upon the exchange of Exchangeable Shares).</span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based in part upon the representations of the sellers in the Valence Purchase Agreement, the offering and sale of the Valence Consideration Shares was made in reliance on the exemption afforded by Section 4(a)(2) of the Securities Act and the rules promulgated thereunder. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None of the Class A Shares issuable in connection with the Cyclica Acquisition and Valence Acquisition (including Class A Shares issuable upon the exchange of Exchangeable Shares, upon the exercise of options to purchase shares of Cyclica assumed by Recursion in the Cyclica Acquisition and upon the exercise of options to purchase shares of Valence assumed by Recursion in the Valence Acquisition) are expected to be registered under the Securities Act or any state securities laws as of the completion of the Cyclica Acquisition and Valence Acquisition, respectively, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from the registration requirements. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of Class A Shares or other Recursion securities or those of any other issuer.</span></div><div><span><br/></span></div><div id="i3515f90243794557b6b778e9763d5abc_60"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01.&#160;&#160;&#160;&#160;Regulation FD Disclosure</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 8, 2023, the Company issued a press release announcing the Cyclica Acquisition and the Valence Acquisition. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information furnished in this Item 7.01 (including Exhibit 99.1), shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Forward Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company cautions you that statements contained in this report includes or is based upon &#8220;forward-looking statements&#8221; within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding closing conditions and the events to occur upon closing of the Cyclica Acquisition and the Valence Acquisition, the exercise of options, the exchange of Exchangeable Shares, and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements such as those described under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s filings with the SEC, including the Company&#8217;s most recent Annual Report on Form 10-K. All forward-looking statements are based on management&#8217;s current estimates, projections, and assumptions, and the Company undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.</span></div><div><span><br/></span></div><div id="i3515f90243794557b6b778e9763d5abc_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991cyclicaandvalencepres.htm">Press release for the Cyclica Acquisition and the Valence Acquisition issued by the Company on May 8, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3515f90243794557b6b778e9763d5abc_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on May&#160;8, 2023.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RECURSION PHARMACEUTICALS, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher Gibson</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Christopher Gibson</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991cyclicaandvalencepres.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie427b3d1d3074f8f90596695cec1e85b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Exhibit 99.1</font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:100%">Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SALT LAKE CITY, TORONTO &#38; MONTR&#201;AL (May 8, 2023)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; </font><font style="background-color:#ffffff;color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Recursion</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (NASDAQ&#58; RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space&#58; </font><font style="background-color:#ffffff;color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cyclica</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="background-color:#ffffff;color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Valence</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;Recursion has pioneered the massive, parallel generation of -omics data with machine learning in order to map and navigate biology to discover new medicines faster. The strategic acquisitions of Cyclica and Valence add industry-leading capabilities in digital chemistry, as well as machine-learning and artificial intelligence, which combined with our large-scale automated wet-laboratories and supercomputing capabilities, enables us to deploy what I believe is the most complete, technology-enabled drug discovery solution in the biopharma industry. We look forward to showing the world proof of the compounding benefit of this full-stack approach through the rapid acceleration of our pipeline and partnerships. Amidst a rapidly accelerating global race for technology talent, these acquisitions cement Recursion as the center of gravity for the best and brightest in ML and AI who want to reimagine how drugs are discovered,&#8221; said Chris Gibson, Ph.D., Co-Founder and CEO of Recursion. &#8220;I am so excited to welcome the Cyclica and Valence teams to Recursion, especially at such a dynamic moment in history when machine learning and artificial intelligence are creating so much rapid change across every industry.&#8221;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Cyclica</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, headquartered in Toronto, has built two highly differentiated products in the digital chemistry space which will be integrated into the RecursionOS. MatchMaker&#8482; is an AI-enabled deep learning engine that predicts the polypharmacology of small molecules as the foundation for small molecule drug discovery. It is able to generalize across the proteome and uses both AlphaFold2 structures and homology models. POEM&#8482; (Pareto Optimal Embedding Model) is a unique similarity-based property prediction model. In contrast to other AI prediction models, POEM uses multiple types of molecular fingerprints to describe molecules, providing a much richer measure of similarity that leads to greater accuracy.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;Cyclica and Recursion both believe in the value of industrializing drug discovery,&#8221; said Naheed Kurji, CEO and Co-Founder of Cyclica. &#8220;Combining our proteome-wide prediction of small molecule-target interactions into Recursion&#8217;s data universe will create one of the largest fit-for-purpose biological and chemical datasets in the drug discovery space. Together, I believe Recursion will have an immense impact on human health in the years to come.&#8221;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Valence</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, headquartered in Montr&#233;al at Mila, the world&#8217;s largest deep learning research institute, is committed to unlocking the full potential of deep learning in the drug discovery process. The company has pioneered the application of low-data learning in drug design, unlocking the ability to design differentiated small molecules with improved properties and function from datasets too small, sparse, or noisy for traditional deep learning methods. Valence has an unparalleled track record of innovation in molecular machine learning, including best-in-class methods for AI-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">enabled structural biology, generative chemistry, and multi-parametric optimization, ultimately enabling the design of best-in-class or first-in-class chemistry against challenging biology.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;The integration of Valence&#8217;s powerful AI-based chemistry engine into Recursion&#8217;s diverse and data-rich operating system will help unlock the true power of AI-first digital chemistry and drug discovery,&#8221; said Daniel Cohen, CEO and Co-founder at Valence Discovery. &#8220;Recursion is a leader in technology-enabled drug discovery with a proven track record of leveraging data to uncover novel biology, and I&#8217;m thrilled for our teams to join forces and combine our respective strengths to rapidly advance new medicines to patients who need them.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Joining forces with Recursion&#8217;s Montr&#233;al deep learning research office, Valence will become an artificial intelligence and machine learning research center to be led by Daniel Cohen with continued advisory from Yoshua Bengio.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8220;The acquisition of Valence gives Recursion the opportunity to create a true center of excellence for some of the most compelling AI&#47;ML research in the world,&#8221; said Yoshua Bengio, deep learning pioneer and scientific advisor to both Recursion and Valence.  &#8220;With this newly integrated group housed in the Mila ecosystem, Recursion's team of researchers in AI and ML for drug discovery reaches a critical mass at a crucial time in the development of new AI algorithms for scientific discovery.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Terms of the Acquisitions</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Recursion has entered into agreements to acquire Cyclica for a purchase price of $40 million and Valence for a purchase price of $47.5 million, in each case subject to customary closing and post-closing purchase price adjustments. The purchase price in the acquisitions will be payable in the form of shares of Recursion Class A common stock, shares of a subsidiary of Recursion exchangeable for shares of Recursion&#8217;s Class A common stock and the assumption of certain outstanding Valence and Cyclica options. In certain limited circumstances, Recursion may pay nominal cash consideration to Valence and Cyclica shareholders in lieu of such exchangeable shares or Recursion Class A common stock. Recursion expects no material change to its cash runway as a result of these acquisitions. Recursion expects both acquisitions to be completed in the second quarter of 2023, subject to applicable closing conditions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Recursion</font></div><div><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Recursion</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world&#8217;s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale &#8212; up to millions of wet lab experiments weekly &#8212; and massive computational scale &#8212; owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Recursion is headquartered in Salt Lake City, where it is a founding member of </font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">BioHive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montr&#233;al and the San Francisco Bay Area. Learn more at </font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">www.Recursion.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, or connect on </font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> and</font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline"> LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Cyclica</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">As a neo-biotech, Cyclica is efficiently advancing an industry-leading, robust and sustainable drug discovery portfolio focused on CNS, oncology, and auto-immune diseases. Cyclica has built the only generalizable platform across the entire proteome, expanding the target space for low-data targets, including AlphaFold2 structures, PPIs, and mutant oncogenic targets. Cyclica has brought together a diverse and experienced team of biologists, chemists, computer scientists, and business professionals who are collectively passionate about changing the drug discovery paradigm. By exploring the unexplored, and drugging the undrugged, Cyclica strives to impact patient health like never before. For more information, please visit&#58;</font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">www.cyclicarx.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Valence Discovery</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Valence is harnessing a revolution in computation to improve human health. The company is a leader in developing and deploying AI and physics-based technologies to enable the design of differentiated small molecules with improved properties and function. Following successful partnerships with leading biotech and pharmaceutical companies, and an unparalleled track record of innovation featured in top AI journals and conferences, Valence has built a team of interdisciplinary industry veterans and computational experts focused on rapidly advancing a portfolio of internal drug discovery programs. Valence launched publicly in 2021, is supported by leading biotech and deeptech investors, and is headquartered in Montr&#233;al. To learn more, please visit</font><font style="color:#65b4b4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">www.valencediscovery.com</font><font style="color:#65b4b4;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Media Contact</font></div><div><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Media&#64;Recursion.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Investor Contact</font></div><div><font style="color:#1155cc;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Investor&#64;Recursion.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">This document contains information that includes or is based upon &#34;forward-looking statements&#34; within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the timing and completion of the Cyclica and Valence acquisitions and the outcomes and benefits expected from such acquisitions&#59; Recursion OS and other technologies&#59; business and financial plans and performance, including cash runway&#59; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to&#58; challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors&#59; our ability to leverage and enhance our drug discovery platform&#59; our ability to obtain financing for development activities and other corporate purposes&#59; the success of our collaboration activities&#59; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates&#59; our ability to obtain, maintain, and enforce intellectual property protections&#59; cyberattacks or other disruptions to our technology systems&#59; our ability to attract, motivate, and retain key employees and manage our growth&#59; inflation and other macroeconomic issues&#59; and other risks and uncertainties such as those described under the heading &#8220;Risk Factors&#8221; in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K. All forward-looking statements are based on management&#8217;s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rxrx-20230508.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d44ab27f-8d2b-476f-a18d-ac4021c2411b,g:867c0a93-9133-4bf0-a465-6221de68719c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rxrx="http://www.recursion.com/20230508" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.recursion.com/20230508">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20230508_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20230508_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.recursion.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rxrx-20230508_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d44ab27f-8d2b-476f-a18d-ac4021c2411b,g:867c0a93-9133-4bf0-a465-6221de68719c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_c9e4f65d-a3d9-458f-9a78-a3ec5673b818_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_87e6dc79-52fa-4075-9fba-e1a252032943_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a042f3f4-133d-4afa-b153-8a7cfebd223c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d5922669-3dde-4806-afdb-88e2090d8bfd_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_71cee554-df1b-4d1d-9731-3fb30c993819_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c2ea728d-17c4-408d-93e6-09d5d2957811_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_dff588c0-e120-4f48-811e-e3bdf1886c84_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3fe89bcd-5431-41c4-b9c4-87efdabaf91e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7a800ca8-d978-4cdb-bdd9-869b027d8509_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_367c755c-014f-4341-bc51-88c3db3b315a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3611a2e2-f357-4290-8065-cedcd7dcbe89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_90e1b4e2-40b3-44f3-a260-5422be3d8f81_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5870d9cf-5c92-4b3a-9aa5-e7f7db50f892_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1f6dc691-750e-4190-8b26-fafec32ef536_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7d2c4f09-20ce-42aa-a018-5596efeaf7e3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_a24f04a9-54b7-4068-ae58-111fd84c619d_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_41729eda-918d-4794-9e48-34034f6b1dd2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_74174282-dd9d-49d3-b36c-83517504efda_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9d1b3555-d045-421c-a693-47acca98efe8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_833139a6-2dde-4f69-ae4f-41ebf116f3dd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_759b94b0-3c3a-4306-b43c-06f7e407e1ad_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b359d2e5-bd25-47d9-bd96-73886cd57ebd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f73076aa-afb4-42ec-862a-6c1bec06aa9f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rxrx-20230508_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d44ab27f-8d2b-476f-a18d-ac4021c2411b,g:867c0a93-9133-4bf0-a465-6221de68719c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.recursion.com/role/Cover" xlink:type="simple" xlink:href="rxrx-20230508.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2defea9b-4e50-44f3-94b1-ddaca52c6001" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_DocumentType_2defea9b-4e50-44f3-94b1-ddaca52c6001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ab9760b1-2de1-44ae-8e52-cde3bd97c971" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_DocumentPeriodEndDate_ab9760b1-2de1-44ae-8e52-cde3bd97c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6bc6082d-581f-4f37-853c-c7e76d433c19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityRegistrantName_6bc6082d-581f-4f37-853c-c7e76d433c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_083bfaab-edbf-4d78-9246-99e7cf6a19f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_083bfaab-edbf-4d78-9246-99e7cf6a19f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f38fe2ca-2ed5-4d15-b92e-2ee82cd698a6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityFileNumber_f38fe2ca-2ed5-4d15-b92e-2ee82cd698a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bd17ffbb-9d25-46cb-a131-ed1d4a4d3dea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityTaxIdentificationNumber_bd17ffbb-9d25-46cb-a131-ed1d4a4d3dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_04c979e3-8304-4ffa-9284-8499134564b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityAddressAddressLine1_04c979e3-8304-4ffa-9284-8499134564b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6838556b-4932-41a0-8597-cd8e149b8ddd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityAddressCityOrTown_6838556b-4932-41a0-8597-cd8e149b8ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_93f6cdfd-ce35-47db-8b66-89064f796f22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityAddressStateOrProvince_93f6cdfd-ce35-47db-8b66-89064f796f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1c6ecab0-2ef1-4064-aace-72482eb624d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityAddressPostalZipCode_1c6ecab0-2ef1-4064-aace-72482eb624d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_318b8a8d-5943-4de0-9f2d-9ffdf5af00c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_CityAreaCode_318b8a8d-5943-4de0-9f2d-9ffdf5af00c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6b247d22-5116-481b-b6c7-5c1109166cd1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_LocalPhoneNumber_6b247d22-5116-481b-b6c7-5c1109166cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_816168f6-c27b-4e7f-bc6e-5eb651330e0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_WrittenCommunications_816168f6-c27b-4e7f-bc6e-5eb651330e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a330f47a-3147-476a-8bfe-0a4f4622ceb7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_SolicitingMaterial_a330f47a-3147-476a-8bfe-0a4f4622ceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9271c231-071d-4b9d-90bb-c2b8a27beb3f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_PreCommencementTenderOffer_9271c231-071d-4b9d-90bb-c2b8a27beb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_cf486cf1-a9c5-45d8-a210-64b4b7f134f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_cf486cf1-a9c5-45d8-a210-64b4b7f134f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_640d1cfc-eabf-486e-997d-60a979b4432f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_Security12bTitle_640d1cfc-eabf-486e-997d-60a979b4432f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_95c58b1e-62b8-4e54-ab13-26ac41642bed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_TradingSymbol_95c58b1e-62b8-4e54-ab13-26ac41642bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1f4a2ad6-2b43-45b7-814f-2b0119c60576" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_SecurityExchangeName_1f4a2ad6-2b43-45b7-814f-2b0119c60576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_358d6913-2492-4ce3-ac4b-584903d57db2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityEmergingGrowthCompany_358d6913-2492-4ce3-ac4b-584903d57db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_c0db34b5-77fb-4c6a-9433-15fb5c663cb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityExTransitionPeriod_c0db34b5-77fb-4c6a-9433-15fb5c663cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_03af42d0-3c52-4089-b88f-57c76835c726" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_EntityCentralIndexKey_03af42d0-3c52-4089-b88f-57c76835c726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_92400528-4895-4476-bbd1-fac2f34b2a0a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0c4b3687-cc10-401b-9145-fe3b333089a2" xlink:to="loc_dei_AmendmentFlag_92400528-4895-4476-bbd1-fac2f34b2a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139687249826976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  08,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RECURSION PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4099738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41 S Rio Grande Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269 - 0203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RXRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>rxrx-20230508_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rxrx-20230508.xsd" xlink:type="simple"/>
    <context id="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2023-01-13</startDate>
            <endDate>2023-01-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY180L2ZyYWc6ZmIwMzQzODU1YzA4NDg2M2JhZjkyYjI2N2ExZGQ2YWYvdGFibGU6YTk1YjRjYjdlNWI1NDM5OGE5OWRkMzZmMmQ1NGE4ZWYvdGFibGVyYW5nZTphOTViNGNiN2U1YjU0Mzk4YTk5ZGQzNmYyZDU0YThlZl8xLTEtMS0xLTEwMTQ0Mw_33c76cd7-af83-4710-8881-51c1ebf5ff7c">0001601830</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY180L2ZyYWc6ZmIwMzQzODU1YzA4NDg2M2JhZjkyYjI2N2ExZGQ2YWYvdGFibGU6YTk1YjRjYjdlNWI1NDM5OGE5OWRkMzZmMmQ1NGE4ZWYvdGFibGVyYW5nZTphOTViNGNiN2U1YjU0Mzk4YTk5ZGQzNmYyZDU0YThlZl8yLTEtMS0xLTEwMTQ0Mw_7536b49c-a71a-4139-9076-aade82727435">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjUz_86f660b8-5266-4b8e-b9f1-052c4ba89471">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yMjc_5705ffd0-c431-45e2-a788-110f7e72d926">2023-05-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yMzE_2747b360-915f-47da-b962-662a70ba83e4">RECURSION PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6YzQ2MDlkMjU4MDU0NDcyNWEwYjlmOGM5Mjg3YzllMmYvdGFibGVyYW5nZTpjNDYwOWQyNTgwNTQ0NzI1YTBiOWY4YzkyODdjOWUyZl8wLTAtMS0xLTEwMTQ0Mw_504502c4-7525-46ef-9440-742a556c2272">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6YzQ2MDlkMjU4MDU0NDcyNWEwYjlmOGM5Mjg3YzllMmYvdGFibGVyYW5nZTpjNDYwOWQyNTgwNTQ0NzI1YTBiOWY4YzkyODdjOWUyZl8wLTItMS0xLTEwMTQ0Mw_9a5d9f57-f228-4263-af50-686d148ba309">001-40323</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6YzQ2MDlkMjU4MDU0NDcyNWEwYjlmOGM5Mjg3YzllMmYvdGFibGVyYW5nZTpjNDYwOWQyNTgwNTQ0NzI1YTBiOWY4YzkyODdjOWUyZl8wLTQtMS0xLTEwMTQ0Mw_9d5165b2-eabf-4a29-82ee-6d89a4a4055a">46-4099738</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yOTQ_db5b0049-ed1a-4505-a86a-f4ab0033c97e">41 S Rio Grande Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8yOTc_876f19de-c11d-4eb4-97a8-dbf0fb500381">Salt Lake City,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zMDA_8f0710fd-8073-4447-a27d-145a6a783501">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zMDM_2dad24d7-3771-49e2-8203-1694c0a2f7c1">84101</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zNjA_f964c9e9-c38f-4238-b074-aee900320fad">385</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8zNjQ_a8c469ac-975c-4a14-90ba-851556fe9457">269 - 0203</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjU1_64938900-b014-46e6-8a5b-14263586c2a9">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjU5_fd67078f-8e0d-4393-86b2-625039ae3fa8">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjU2_c34dd2da-3b14-4aa3-8c29-097de0551d22">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjUy_e66e4e68-cbb9-43e8-bce8-da34bde790ec">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6ZGJhMWZjZGNlOTVhNDQzN2FmNzBkNTg0NmI0MjY0Y2MvdGFibGVyYW5nZTpkYmExZmNkY2U5NWE0NDM3YWY3MGQ1ODQ2YjQyNjRjY18xLTAtMS0xLTEwMTQ0Mw_4733f9b4-c80e-45d6-b8f9-e0dd9fae57b4">Class A Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6ZGJhMWZjZGNlOTVhNDQzN2FmNzBkNTg0NmI0MjY0Y2MvdGFibGVyYW5nZTpkYmExZmNkY2U5NWE0NDM3YWY3MGQ1ODQ2YjQyNjRjY18xLTEtMS0xLTEwMTQ0Mw_528df04f-ed27-463f-96c2-b56a25eb2db7">RXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGFibGU6ZGJhMWZjZGNlOTVhNDQzN2FmNzBkNTg0NmI0MjY0Y2MvdGFibGVyYW5nZTpkYmExZmNkY2U5NWE0NDM3YWY3MGQ1ODQ2YjQyNjRjY18xLTItMS0xLTEwMTQ0Mw_2d250473-8ed4-4727-9bb0-a7cce243036b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113"
      id="id3VybDovL2RvY3MudjEvZG9jOjM1MTVmOTAyNDM3OTQ1NTdiNmI3NzhlOTc2M2Q1YWJjL3NlYzozNTE1ZjkwMjQzNzk0NTU3YjZiNzc4ZTk3NjNkNWFiY18xL2ZyYWc6YTRmYmQ4ZTc1NGNhNGY4Zjk5OGZiNWFkNjJmNTY1NmUvdGV4dHJlZ2lvbjphNGZiZDhlNzU0Y2E0ZjhmOTk4ZmI1YWQ2MmY1NjU2ZV8xNjYx_49212511-ba5f-48f5-9693-d52d91294d17">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ #D"H5JK$(A8S 0  (@(   \
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M4$L! A0#%     @ #D"H5M-O037N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ #D"H5IE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  .0*A6T-N7S6($  "=$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ #D"H5I^@&_"Q @  X@P
M  T              ( !I0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  .
M0*A6EXJ[',     3 @  "P              @ &!#P  7W)E;',O+G)E;'-0
M2P$"% ,4    "  .0*A6JL0B%C,!   B @  #P              @ %J$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ #D"H5B0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ #D"H5F60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rxrx-20230508.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="rxrx-20230508.htm">rxrx-20230508.htm</File>
    <File>ex991cyclicaandvalencepres.htm</File>
    <File>rxrx-20230508.xsd</File>
    <File>rxrx-20230508_lab.xml</File>
    <File>rxrx-20230508_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rxrx-20230508.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "rxrx-20230508.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rxrx-20230508_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rxrx-20230508_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rxrx-20230508.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rxrx",
   "nsuri": "http://www.recursion.com/20230508",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rxrx-20230508.htm",
      "contextRef": "i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.recursion.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rxrx-20230508.htm",
      "contextRef": "i2db9742d9d3b43ff8b9660356bdec03e_D20230113-20230113",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001601830-23-000021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601830-23-000021-xbrl.zip
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M7[(>V1 P0@E].%-&<ZN#&G&<@NA9:<]E++3CQD"F&@[@W#?X1 @!2_+@)9=
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M*'S$ZW*$D*D&*RLA->*O<KMR!+/9S&M,?@[:5V\E*-%V)-XLA\5C<\1!B*/
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M_/.2U<6NKW=S7LRF,J((Q3$%6$H%2!K&@&G)09HJ%-)0IES+OF)O63XV@:_
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MF@,+TY$5KS6GS?5!Z\Z6P='7GC9W;.M/:SO?Q/B+NLCJ:E->->..2LAQ%$5
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M%;-C;ECT9UR3?+YXDT7]U>J1>&=PX&CO_H?NI?N?Q-'>_P%02P$"% ,4
M"  .0*A6LFY_L6X4  #X30  '@              @ $     97@Y.3%C>6-L
M:6-A86YD=F%L96YC97!R97,N:'1M4$L! A0#%     @ #D"H5GA0&Q+V&@
MP)L  !$              ( !JA0  ')X<G@M,C R,S U,#@N:'1M4$L! A0#
M%     @ #D"H5D[+6XYH @  <0<  !$              ( !SR\  ')X<G@M
M,C R,S U,#@N>'-D4$L! A0#%     @ #D"H5JR@"7^L"@  _V   !4
M         ( !9C(  ')X<G@M,C R,S U,#A?;&%B+GAM;%!+ 0(4 Q0    (
M  Y J%:VJ $.WP8  /4R   5              "  44]  !R>')X+3(P,C,P
A-3 X7W!R92YX;6Q02P4&      4 !0!0 0  5T0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
